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PPeripheral Vascular Disease
Associations of Borderline and
Low Normal Ankle-Brachial Index Values
With Functional Decline at 5-Year Follow-Up
The WALCS (Walking and Leg Circulation Study)
Mary M. McDermott, MD,*† Jack M. Guralnik, MD, PHD,‡ Lu Tian, SCD,† Kiang Liu, PHD,†
Luigi Ferrucci, MD, PHD,§ Yihua Liao, MS,† Leena Sharma, MD,* Michael H. Criqui, MD, MPH
Chicago, Illinois; Baltimore, Maryland; and San Diego, California
Objectives We studied associations of borderline and low normal ankle-brachial index (ABI) values with functional decline
over a 5-year follow-up.
Background The associations of borderline and low normal ABI with functional decline are unknown.
Methods The 666 participants included 412 with peripheral arterial disease (PAD). Participants were categorized as fol-
lows: severe PAD (ABI 0.50), moderate PAD (ABI 0.50 to 0.69), mild PAD (ABI 0.70 to 0.89), borderline ABI
(0.90 to 0.99), low normal ABI (1.00 to 1.09), and normal ABI (ABI 1.10 to 1.30). Outcomes were assessed an-
nually for 5 years. Mobility loss was defined as loss of the ability to walk one-quarter mile or walk up and down
1 flight of stairs without assistance among participants without baseline mobility impairment. Becoming unable
to walk for 6 min continuously was defined as stopping during the 6-min walk at follow-up among those who
walked for 6 min continuously at baseline. Results were adjusted for age, sex, race, comorbidities, and other
confounders.
Results Hazard ratios (HRs) for mobility loss according to ABI category were as follows: severe PAD, HR: 4.16 (95% con-
fidence interval [CI]: 1.58 to 10.92); moderate PAD, HR: 3.82 (95% CI: 1.66 to 8.81); mild PAD, HR: 3.22 (95%
CI: 1.43 to 7.21); borderline ABI, HR: 3.07 (95% CI: 1.21 to 7.84); and low normal ABI, HR: 2.61 (95% CI: 1.08
to 6.32; p trend  0.0018). Similar associations were observed for becoming unable to walk for 6 min continu-
ously (p trend  0.0001).
Conclusions At 5-year follow-up, persons with borderline ABI values have a higher incidence of mobility loss and becoming
unable to walk for 6 min continuously compared with persons who have a normal baseline ABI. A low normal
ABI is associated with an increased incidence of mobility loss compared with persons who have a normal
ABI. (J Am Coll Cardiol 2009;53:1056–62) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.09.063p
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iight million men and women in the U.S. have lower
xtremity peripheral arterial disease (PAD). The prevalence
f PAD is expected to increase as the population survives
onger with chronic disease (1,2). PAD is common among
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008, accepted September 10, 2008.atients age 50 years and older in primary care medical
ractices and is frequently underdiagnosed (3,4). Among
ommunity-dwelling populations, the prevalences of low
ormal and borderline ankle-brachial index (ABI) values are
imilar to or higher than PAD (5,6). Persons with PAD,
See page 1063
efined as an ABI 0.90, have greater functional impair-
ent and faster rates of functional decline than do persons
ithout PAD (7,8). However, associations of borderline
nd low normal ABI values with functional decline are
nknown.
The ABI is a ratio of Doppler-recorded systolic pressures
n the lower and upper extremities. In persons without
AD, arterial pressures increase with greater distance from
t
a
p
p
a
s
(
b
A
s
c
1
i
b
o
n
o
H
A
a
f
m
W
b
d
t
M
S
N
H
i
n
d
C
s
w
b
P
b
f
P
i
a
v
w
i
e
w
P
l
l
a
i
N
P
i
l
p
l
m
c
e
n
l
t
P
A
p
r
g
r
s
n
d
c
p
s
t
i
n
h
p
t
t
e
n
n
i
A
V
r
b
E
d
p
(
p
b
w
p
d
b
l
d
m
1057JACC Vol. 53, No. 12, 2009 McDermott et al.
March 24, 2009:1056–62 Borderline Ankle-Brachial Index Valueshe heart, because of increasing impedance with increasing
rterial taper (9). This phenomenon results in higher systolic
ressures at the ankle compared with the brachial arteries in
ersons without PAD. Thus, persons without lower extremity
therosclerosis have an ABI 1.00. An ABI 0.90 is highly
ensitive and specific for angiographically-diagnosed PAD
10). However, recent data show that even persons with
orderline ABI values (ABI 0.90 to 0.99) and low normal
BI values (ABI 1.00 to 1.09) have higher prevalences of
ubclinical atherosclerosis in the coronary and cerebrovas-
ular arterial beds than do persons with an ABI of 1.10 to
.30 (5). Prevalences of intermittent claudication and atyp-
cal exertional leg pain are higher among persons with
orderline ABI values than among persons with ABI values
f 1.10 to 1.40 (11). Thus, persons with borderline and low
ormal ABI values may experience higher rates of adverse
utcomes than persons with ABI values of 1.10 to 1.30.
owever, the associations of borderline and low normal
BI values with functional decline are unknown.
In this prospective, observational study, we describe associ-
tions between baseline ABI values and annually measured
unctional outcomes, assessed up to 5 years after baseline
easures, in a large cohort of persons with and without PAD.
e hypothesized that participants with low normal and
orderline baseline ABI values would have rates of functional
ecline that are less than participants with PAD but greater
han persons with a normal ABI at baseline.
ethods
tudy overview. The Institutional Review Boards of
orthwestern University and Catholic Health Partners
ospital approved the protocol. Participants gave written
nformed consent. The funding source for this study played
o role in the design, conduct, reporting of the study, or
ecision to submit the manuscript.
Participants were part of the WALCS (Walking and Leg
irculation Study), a prospective, observational study de-
igned to identify predictors of functional decline in persons
ith and without PAD (7,8,12). Participants underwent
aseline assessment and returned annually for follow-up.
articipants unable to return for follow-up were interviewed
y telephone for the mobility outcome measure. Mean
ollow-up was 54 months.
articipant identification. Participants with PAD were
dentified from among consecutive patients ages 55 years
nd older diagnosed with PAD in 3 Chicago-area nonin-
asive vascular laboratories (7,8). The PAD participants
ere identified from among consecutive patients with PAD
n the noninvasive vascular laboratory because this is an
fficient method to identify large numbers of PAD patients
ith a wide range of PAD severity. Participants without
AD were identified from among persons with normal
ower extremity arterial studies at the 3 noninvasive vascular
aboratories and from among consecutive patients with 0ppointments in a large general
nternal medicine practice at
orthwestern. Identifying non-
AD participants from the non-
nvasive vascular laboratory al-
owed us to include non-PAD
articipants with a higher preva-
ence of leg symptoms and co-
orbidities who were relatively
omparable to PAD participants
xcept for the presence versus absence of PAD. Identifying
on-PAD participants from general medicine practice al-
owed us to include non-PAD participants more typical of
he non-PAD patients encountered by practicing clinicians.
articipants from general internal medicine who had a low
BI at their study visit were included among PAD
articipants.
Exclusion criteria for the WALCS study have been
eported (7,8,12) and include dementia, recent major sur-
ery, above or below knee amputations, nursing home
esidence, and wheelchair confinement. Non–English-
peaking patients were excluded because investigators were
ot fluent in non-English languages. Persons with PAD
iagnosed in the noninvasive vascular laboratory were ex-
luded if their baseline visit ABI was 0.95. Similarly,
ersons whose noninvasive vascular laboratory testing
howed no PAD were excluded if their ABI was 0.95 at
heir study visit. This ABI threshold was used because this
s the ABI threshold used to define PAD in Northwestern’s
oninvasive vascular laboratory. This exclusion criterion
elped minimize misclassification bias, for example, in
articipants who may have had a low toe-brachial index in
he noninvasive vascular laboratory but had a normal ABI at
heir study visit. Participants with baseline ABI 1.30 were
xcluded from analyses. Participants with ABI 1.30 have
oncompressible lower extremity vessels and therefore could
ot be accurately classified into our ABI categories of
nterest (5,13).
BI measurement. A hand-held Doppler probe (Nicolet
ascular Pocket Dop II, Nicolet Biomedical, Golden, Colo-
ado) was used to obtain systolic pressures in the right and left
rachial, dorsalis pedis, and posterior tibial arteries (7,8,14).
ach pressure was measured twice. The ABI was calculated by
ividing the mean of the dorsalis pedis and posterior tibial
ressures in each leg by the mean of the 4 brachial pressures
15). Zero values for the dorsalis pedis and posterior tibial
ulses were set to missing for the ABI calculation. Average
rachial pressures in the arm with highest pressure were used
hen 1 brachial pressure was higher than the opposite brachial
ressure in both measurement sets and the 2 brachial pressures
iffered by 10 mm Hg or more in at least 1 measurement set,
ecause in such cases subclavian stenosis was possible (15). The
owest leg ABI was used in analyses. The ABI categories were
efined a priori as follows (5,8): severe PAD (ABI 0.50),
oderate PAD (ABI 0.50 to 0.69), mild PAD (ABI 0.70 to
Abbreviations
and Acronyms
ABI  ankle-brachial index
BMI  body mass index
CI  confidence interval
HR  hazard ratio
PAD  peripheral arterial
disease.89), borderline PAD (ABI 0.90 to 0.99), low normal ABI
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Borderline Ankle-Brachial Index Values March 24, 2009:1056–62ABI 1.00 to 1.09), and normal ABI (ABI 1.10 to 1.30). These
BI categorizations were defined based on prior study (5,8)
nd allowed us to assess associations of ABI with study
utcomes across a wide range of ABI values.
utcomes. Our primary outcome measures were mobility
oss and becoming unable to walk for 6 min continuously
ithout stopping (8,12,16). These outcomes were assessed
nnually at each follow-up visit and were selected because
hey represent clearly defined, discrete end points. These
utcomes avoid a possible “floor” effect that may occur with
nnual changes in distance achieved in the 6-min walk, for
xample, when a participant becomes unable to walk but
annot further deteriorate in functional performance. Sec-
ndary outcomes were a 15% decline in 6-min performance
nd a 20% decline in 6-min walk performance.
-min walk. The 6-min walk was administered at baseline
nd at each annual follow-up visit. The 6-min walk test has
xcellent test-retest reliability in persons with PAD (17,18).
ollowing a standardized protocol (7,8,12,17–19), partici-
ants walk up and down a 100-foot hallway for 6 min after
nstructions to cover as much distance as possible. The
nterviewer administering the test records whether the
articipant stopped during the 6-min walk. Participants
ho stopped at baseline were excluded from analyses of
ecoming unable to walk for 6 min continuously.
obility measures. A critical factor in an older person’s
bility to function independently in the community is mobility,
efined as the ability to walk or climb stairs without assistance
16). Older people who lose mobility are less likely to remain in
he community, have higher rates of morbidity, mortality, and
ospitalizations, and experience a poorer quality of life
16,19,20). Based on previous study, mobility loss was defined
s becoming unable to walk up and down 1 flight of stairs or
alk one-quarter mile without assistance among patients
ithout mobility impairment at baseline (20,21). At baseline
nd at each follow-up visit, participants were asked to indicate
hether they were able to walk one-quarter mile and whether
hey could climb up and down 1 flight of stairs: 1) on their
wn; 2) with assistance; or 3) not at all (20,21).
omorbidities. Comorbidities assessed were diabetes melli-
us, angina, myocardial infarction, heart failure, cancer, chronic
ung disease, lower extremity arthritis, spinal stenosis, spinal
isk disease, and stroke. Disease-specific algorithms that com-
ine data from patient report, medical record review, medica-
ions, laboratory values, and a questionnaire completed by the
articipant’s primary care physician were used to verify and
ocument baseline comorbidities other than knee and hip
rthritis, on the basis of criteria previously developed (22).
merican College of Rheumatology criteria were used to
ocument the presence of knee and hip osteoarthritis (23,24).
ther measures. Height and weight were measured at the
tudy visit. Body mass index (BMI) was calculated as
weight [kg]/height [m])2. Cigarette smoking history was
etermined with patient report. At baseline, participants
ere asked to report the number of blocks they walked
uring the previous week. At each follow-up visit, we used batient report, a primary care physician questionnaire, and
edical record review to identify lower extremity revascu-
arizations each year.
tatistical analyses. Baseline characteristics of participants in
ach ABI category were compared using general linear models
or continuous variables and chi-square tests for categorical
ariables. Functional outcomes were mobility loss among
articipants without mobility impairment at baseline and loss
f the ability to walk continuously for 6 min without stopping
mong participants who completed the 6-min walk test with-
ut stopping at baseline. Secondary functional outcome mea-
ures were 15% and 20% declines, respectively, in 6-min walk
erformance.
Cox regression analyses were used to compare rates of each
unctional outcome across ABI categories, adjusting for age,
ex, race, and baseline values for comorbidities, smoking, body
ass index, and patient-reported blocks walked during the
rior week. The ABI categories were entered as dummy
ariables into the regression analyses. Participants who met our
rimary outcome definitions at baseline (mobility impairment
r inability to walk for 6 min without stopping) were excluded
rom these respective analyses. Person-time was calculated as
he number of months from the baseline visit to the date of the
ost recent visit (last seen) or the date of the visit during which
ach functional outcome of interest was first reported, which-
ver came first. Participants who died before experiencing an
utcome measure or who underwent lower extremity revascu-
arization during follow-up were censored at the date of their
ast visit before these events. These analyses were repeated, in
hich death was considered as an outcome if it occurred before
obility loss or stopping during the 6-min walk, respectively.
ecause lower extremity arthritis and spinal disk disease may
nfluence rates of functional decline, Cox regression analyses
ere repeated within the subset of participants with no history
f knee arthritis, hip arthritis, disk disease, or spinal stenosis.
e also tested for interactions between the presence versus
bsence of knee arthritis, hip arthritis, spinal disk disease, or spinal
tenosis and the association of the ABI with functional outcomes.
We tested the proportional hazards assumption for mobility
oss and the stop during the 6-min walk analyses using
artingale residuals based methods, and we did not find any
ignificant deviation from the proportional hazards assumption
25). Analyses were performed using SAS statistical software,
ersion 9.1 (SAS Institute, Cary, North Carolina).
esults
f 731 men and women who completed baseline testing for
he WALCS study and had a baseline ABI1.30, 698 (95%)
ompleted at least 1 follow-up visit. Of these, 18 underwent
ower extremity revascularization before their first annual
ollow-up visit, leaving 680 participants. Of these, 516 (284
ith PAD) completed the 6-min walk test at baseline without
topping and participated in at least 1 annual follow-up 6-min
alk test. These 516 participants were included in analyses of
ecoming unable to walk for 6 min without stopping. The
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March 24, 2009:1056–62 Borderline Ankle-Brachial Index Valuesorresponding number of participants who were free of mo-
ility impairment at baseline was 647. A total of 666 partici-
ants (412 with PAD) met criteria for inclusion in either the
-min walk or mobility loss analyses.
Table 1 shows characteristics associated with each ABI
ategory at baseline among the 666 participants. Lower ABI
alues were associated with older age, lower BMI, greater
ack-years of cigarette smoking, higher prevalences of
iabetes and history of cardiac or cerebrovascular diseases,
ower prevalences of lower extremity arthritis or spinal disk
isease, and fewer blocks walked during the previous week.
Figure 1 shows adjusted associations of baseline ABI
evels with incident mobility loss among participants with-
ut mobility impairment at baseline. Adjusting for age, sex,
haracteristics of Study Participants According to Baseline ABI Ca
Table 1 Characteristics of Study Participants According to Bas
Characteristic
ABI <0.50
(n  61)
ABI 0.50–0.69
(n  178)
Age, yrs 74.07 8.95 71.66 8.68
Male, % 49.18 62.92
African-American, % 22.95 15.73
ABI 0.42 0.07 0.60 0.06
Body mass index, kg/m2 26.37 4.74 26.76 4.85
Cigarette smoking, pack-yrs 32.78 31.13 36.24 32.7
Diabetes mellitus, % 27.87 34.83
Cardiac or cerebrovascular disease, % 59.02 62.92
Pulmonary disease, % 26.23 25.84
Cancer, % 11.48 11.80
Lower extremity arthritis, disk disease,
or spinal stenosis
31.15 39.89
Number of blocks walked during past week 22.64 33.93 41.53 72.6
BI  ankle-brachial index.
Figure 1 Adjusted Associations of ABI and Mobility Loss
Adjusted associations of baseline ankle-brachial index (ABI) and mobility loss at 5
for age, sex, race, comorbidities, body mass index, smoking, and physical activity
follow-up. Number of events per ABI category: ABI 0.50, n  12; ABI 0.50 to 0.6
n  16; and ABI 1.10 to 1.30, n  8. Number of deaths per ABI category: ABI 0
n  8; ABI 1.00 to 1.09, n  9; and ABI 1.10 to 1.30, n  10.ace, comorbidities, smoking, BMI, and physical activity
evel, lower ABI values were associated with significantly
igher rates of mobility loss (p trend  0.0018). Compared
ith participants with a normal baseline ABI, those with a
aseline ABI 0.50 had a significantly increased risk of
obility loss (p 0.0038) during annual follow-up visits up
o 5-years after baseline (Fig. 1). Compared with the
eference category with normal baseline ABI, increased rates
f mobility loss were observed among participants with ABI
.50 to 0.69 (p  0.0016), ABI 0.70 to 0.89 (p  0.0046),
BI 0.90 to 0.99 (p  0.0187), and ABI 1.00 to 1.09 (p 
.033), adjusting for confounders (Fig. 1). No significant
nteractions were observed between presence versus absence
f knee arthritis, hip arthritis, spinal stenosis, or spinal disk
ry (n  666)
ABI Category (n  666)
0.70–0.89
 173)
ABI 0.90–0.99
(n  62)
ABI 1.00–1.09
(n  78)
ABI 1.10–1.30
(n  114) p Trend
9 7.99 71.60 8.83 70.74 7.90 66.71 7.11 0.0001
58.96 46.77 38.46 65.79 0.7863
13.29 17.74 25.64 13.16 0.8298
9 0.06 0.95 0.03 1.06 0.03 1.17 0.05 0.0001
1 4.72 28.28 4.94 27.63 5.23 28.30 4.84 0.012
1 35.26 26.26 28.83 15.67 21.79 20.89 30.77 0.0001
28.90 24.19 12.82 20.18 0.0009
53.76 41.94 30.77 35.96 0.0001
36.42 29.03 38.46 35.09 0.0573
17.92 22.58 12.82 14.04 0.5715
39.88 56.45 60.26 53.51 0.0001
6 45.92 43.27 55.49 48.77 55.75 56.79 64.5 0.003
llow-up among persons age 55 years and older (n  644). Results are adjusted
. The y-axis shows the hazard ratio representing the risk of mobility loss at 5-year
30; ABI 0.70 to 0.89, n  30; ABI 0.90 to 0.99, n  11; ABI 1.00 to 1.09,
 20; ABI 0.50 to 0.69, n  39; ABI 0.70 to 0.89, n  28; ABI 0.90 to 0.99,tego
eline
ABI
(n
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Borderline Ankle-Brachial Index Values March 24, 2009:1056–62isease and the association of the ABI with mobility loss
data not shown). Results were not substantially changed
hen deaths occurring before mobility loss were included as
utcomes (data not shown).
Adjusting for age, sex, race, smoking, comorbidities, body
ass index, and physical activity level, a significant interac-
ion was observed between presence versus absence of knee
rthritis, hip arthritis, spinal stenosis, or spinal disk disease
nd the association of the ABI with stopping during the
-min walk test (p value for interaction term  0.023). In
his interaction, associations of ABI with becoming unable
o walk continuously for 6 min were not significant among
articipants with history of knee or hip arthritis, spinal
tenosis, or spinal disk disease (data not shown). In contrast,
ower ABI values were associated with increased risk of
ecoming unable to walk continuously for 6 min among
articipants without history of knee or hip arthritis, spinal
tenosis, or spinal disk disease (p trend 0.001) (Fig. 2).
mong participants without history of knee or hip arthritis,
pinal stenosis, or spinal disk disease, compared with the
eference group with ABI of 1.10 to 1.30 at baseline, border-
ine PAD (ABI 0.90 to 0.99) was associated with increased risk
f becoming unable to walk for 6 min continuously without
topping (hazard ratio [HR]: 5.88, 95% confidence interval
CI]: 1.20 to 28.89; p  0.029) (Fig. 2). Compared with the
eference group, a low normal ABI at baseline (ABI 1.00 to
.10) was associated with an increased risk of becoming unable
o walk for 6 min continuously (HR: 3.26, 95% CI: 0.69 to
5.45; p  0.14), but findings were not statistically significant
0
5
10
15
20
25
30
35
ABI <0.50
(n=22)
ABI 0.50-0.69
(n=69)
AB
Figure 2 Associations of ABI and Loss of Ability to Walk Contin
Adjusted associations of baseline ankle-brachial index (ABI) and loss of the ability
older (n  277). Results are adjusted for age, sex, race, comorbidities, body mas
senting the risk of becoming unable to walk continuously for 6 min at 5-year follow
disk disease because of a significant interaction between the presence versus ab
ABI with becoming unable to walk for 6 min continuously. Number of events per AB
ABI 0.90 to 0.99, n  4; ABI 1.00 to 1.09, n  4; and ABI 1.10 to 1.30, n  3.
0.70 to 0.89, n  28; ABI 0.90 to 0.99, n  8; ABI 1.00 to 1.09, n  9; and ABFig. 2). Results were not substantially changed when analyses
ere repeated in which deaths occurring before a participant
topping during the 6-min walk were included as an outcome.
owever, in these additional analyses the association of bor-
erline ABI with becoming unable to walk for 6 min contin-
ously did not reach statistical significance (HR: 1.77, 95% CI:
.93 to 3.36; p  0.08).
Adjusting for age, sex, race, smoking, comorbidities, body
ass index, and physical activity level and compared with the
eference group with a normal baseline ABI, borderline and
ow normal ABI values were not associated significantly with
igher risk of experiencing a 15% or greater decline in 6-min
alk performance or with higher risk of experiencing a 20% or
reater decline in 6-min walk performance (data not shown).
Participants with ABI 1.10 to 1.30 were significantly less
ikely to develop an ABI 0.90 during follow-up compared
ith patients whose baseline ABI was 0.90 to 0.99 and
hose whose baseline ABI was 1.00 to 1.09 (Table 2). We
herefore repeated analyses in Figures 1 and 2 with addi-
ional adjustment for change in ABI during follow-up.
ssociations of borderline and low normal ABI values with
obility loss and becoming unable to walk for 6 min
ontinuously were attenuated or no longer statistically sig-
ificant after this additional adjustment (data not shown).
iscussion
ata presented here show that among 666 men and women
ith and without PAD, those with borderline ABI values of
.89 ABI 0.90-0.99
(n=22)
ABI 1.00-1.09
(n=29)
ABI 1.10-1.30
(n=52)
ly for 6 Min
lk continuously for 6 min at 5-year follow-up among persons ages 55 years and
x, smoking, and physical activity levels. The y-axis shows the hazard ratio repre-
xcluded are participants with knee arthritis, hip arthritis, spinal stenosis, and
of lower extremity arthritis and spinal disk disease and the association of the
gory: ABI 0.50, n  12; ABI 0.50 to 0.69, n  19; ABI 0.70 to 0.89, n  15;
r of deaths per ABI category: ABI 0.50, n  4; ABI 0.50 to 0.69, n  21; ABI
to 1.30, n  10.I 0.70-0
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March 24, 2009:1056–62 Borderline Ankle-Brachial Index Values.90 to 0.99 had significantly higher rates of mobility loss and
ignificantly higher rates of becoming unable to walk for 6 min
ontinuously at 5-year follow-up, compared with persons with
normal baseline ABI of 1.10 to 1.30. In addition, participants
ith low normal ABI values of 1.00 to 1.09 had significantly
igher rates of mobility loss at 5-year follow-up, compared
ith persons who had a normal baseline ABI. These findings
re important because the ABI threshold typically considered
linically important is ABI 0.90. However, data presented
ere demonstrate that even ABI values of 0.90 to 1.09 are
ssociated with higher rates of functional outcomes compared
ith ABI values of 1.10 to 1.30.
An ABI 0.90 is highly sensitive and specific for diag-
osing PAD, compared with lower extremity angiography
10). However, because of increasing impedance with in-
reasing arterial taper, systolic pressures normally increase
ith greater distance from the heart. Thus, a truly normal
BI is1.00 (9). Our finding that persons with low normal
nd borderline ABI values have higher rates of functional
ecline for some outcomes is consistent with prior studies
howing higher prevalences of subclinical atherosclerosis
nd mortality among persons with low normal and border-
ine ABI values (5,13).
In contrast to our findings for mobility loss and loss of the
bility to walk for 6 min continuously, we found no significant
ssociations of borderline or low normal ABI values with a 15%
r 20% decline in 6-min walk performance during 5-year
ollow-up. Reasons for these discrepancies across our outcome
easures are not clear. However, it is possible that becoming
nable to walk for 6 min continuously during follow-up is a
ore specific outcome for walking impairment related to lower
xtremity ischemia than are the outcomes of 15% or 20%
ecline in 6-min walk performance. Participants with border-
ine or low normal ABI values who slow their 6-min walking
peed sufficiently to experience 15% or 20% declines in 6-min
alk performance but do not stop during the 6-min walk at
ollow-up may be experiencing walking disability due to
omorbidities other than leg ischemia.
The mechanism of higher rates of becoming unable to walk
or 6 min continuously and/or mobility loss at 5-year follow-up
mong persons with low normal and borderline ABI values at
aseline cannot be discerned from data presented here. Several
echanisms are possible. First, our results show that partici-
ants with low normal and borderline ABI values are more
ikely to progress to an ABI 0.90 during 5-year follow-up
Associations of Baseline ABI Category With Incrterial Disease Among Participants With Basel
Table 2 Associations of Baseline ABI CategArterial Disease Among Participant
ABI Category
Number of Participants
at Baseline
Numb
Eve
0.90–0.99 62 31
1.00–1.09 77 13
1.10–1.30 111 2
*Data adjusted for age, sex, race, comorbidities, smoking, and body m
ABI  ankle-brachial index.han are participants with normal baseline ABI values. Our fndings suggest that a higher rate of progression of lower
xtremity atherosclerosis among participants with low normal
nd borderline ABI values is a plausible causal pathway for
ndings reported here. Alternatively, low normal and border-
ine ABI values may be markers for other characteristics
ssociated with higher rates of functional decline, such as
resence of atherosclerosis in other arterial beds (5).
It is not clear from our data why an interaction with
resence of knee arthritis, hip arthritis, disk disease, or spinal
tenosis was present for the association of baseline ABI with
he inability to walk continuously for 6 min at follow-up,
hereas no such interaction was observed for the association of
aseline ABI with mobility loss. Differences in these associa-
ions relate to the 6-min walk test being an objective measure,
nd possibly a more accurate measure of actual performance,
hereas the mobility loss outcome is subjective. Alternatively,
nee or hip arthritis and/or disk disease may affect performance
n the 6-min walk to a greater degree than mobility.
tudy limitations. First, participants were identified from ac-
demic medical centers, and it is unclear whether our findings are
eneralizable to persons outside of academic medical centers.
econd, by necessity, participants with mobility impairment at
aseline and those unable to walk for 6 min continuously at
aseline were excluded from analyses of mobility loss and incident
nability to walk for 6 min continuously at follow-up, respectively.
hus, this study does not assess functional changes in these
xcluded persons. Third, unmeasured variables may account for
ssociations of borderline and low normal ABI values with
unctional decline in persons with PAD. Fourth, despite careful
dentification and confirmation of comorbidities and adjustment
or comorbidities in our analyses, we cannot rule out the possibility
hat comorbidities associated with low normal and borderline ABI
alues may contribute to findings reported here. Fifth, the rela-
ively small number of events for becoming unable to walk for 6
in continuously limits statistical power. Finally, our results do
ot include data for disease-specific health-related quality-of-life
easures.
onclusions
t 5-year follow-up, persons who have borderline and low
ormal ABI values are at higher risk for mobility loss
ompared with persons who do not have PAD. Participants
ith borderline ABI values are also at higher risk for
ecoming unable to walk for 6 min continuously at 5-year
PeripheralBI of 0.90 to 1.30*
ith Incident Peripheral
h Baseline ABI of 0.90 to 1.30*
Hazard Ratio
(95% Confidence Interval) Pairwise p Value
1.0 (reference) Not applicable
0.22 (0.11–0.43) 0.001
0.02 (0.00–0.09) 0.001
dex.identin A
ory W
s Wit
er of
ntsollow-up. Further study is needed to confirm the findings
r
a
b
R
N
m
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
K
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s exercise can prevent functional decline in persons with a
orderline or low normal ABI.
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